:quality(70))
Are operational challenges slowing your oncology clinical trials?
As precision medicine increases protocol complexity, narrows eligibility criteria and fragments patient populations, oncology studies are becoming harder to execute. This webinar explores how operational gaps across research sites, sponsors and CROs can slow screening, enrollment and study delivery, and why a more coordinated model is needed to keep pace with scientific progress.
From the medical oncologist's perspective, biomarker-driven therapies are reshaping trial eligibility around narrower molecular subtypes, fresh tissue requirements and more complex endpoints. From the research site perspective, limited screening infrastructure, inconsistent genomic testing and fragmented referral pathways make recruitment less predictable. From the sponsor and CRO perspective, disconnected data systems, inefficient screening funnels and high screen failure rates can delay enrollment and strain study timelines.
By examining these challenges across the oncologist, research site, sponsor, CRO and patient experience perspectives, this session highlights practical ways to improve patient identification, site readiness and data connectivity in oncology clinical trials.